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Available online 11 June 2016AbstractPurpose: To determine upper eyelid ptosis prevalence and some related factors in 44- to 69-year-olds of Shahroud in the north of Iran.
Methods: In 2009, using multi-stage cluster sampling, 300 clusters of 40e64-year-olds were selected in Shahroud city, and all 5190 participants
were invited to be re-examined in 5 years (2014). The current report is the second phase of the study in which 4737 (91.3%) people participated
and underwent vision tests, slit lamp examination, biometry, and ophthalmoscopy in 2014. Upper eyelid ptosis was determined by an
ophthalmologist.
Results: The prevalence of upper eyelid ptosis was 4.7% [95% confidence interval (CI): 4.1e5.4]; 5.2% in women and in 4.0% in men. The
prevalence of bilateral and unilateral ptosis was 1.3% (95% CI: 1.0e1.7) and 3.4% (95% CI: 2.8e4.0), respectively. The observed prevalence of
ptosis was 3.1% in the 45- to 49-year age group and 5.8% in 65- to 69-year-olds. The prevalence of ptosis increased with age. In the multiple
logistic regression model, ptosis prevalence correlated with older age, diabetes (odds ratio ¼ 1.53, 95% CI: 1.16e2.02) and hypertension (odds
ratio ¼ 1.41, 95% CI: 1.03e2.92). Mean corneal astigmatism was 1.02 (95%C]: 0.87e1.18) diopter in ptotic eyes and 0.87 (95% CI: 0.84e0.89)
diopter in non-ptotic eyes ( p ¼ 0.013).
Conclusions: The present report provides valuable information on the prevalence of ptosis in a population of 45-to 69-year-olds. The prevalence
of ptosis in this study was considerably high and significantly increased with age.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ptosis is one of the problems of the upper eyelid which is
seen in adults and children.1 Since the pupillary axis can be
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amblyopia by causing visual deprivation.2,3 However, in
adults, in addition to cosmetic issues, it can restrict the visual
field and affect a person's daily activities and ultimately affect
the patient's quality of life.4,5 In children, most cases of ptosisr and Shahroud University of Medical Sciences.
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Table 1
The prevalence of ptosis by age and gender in the 45- to 69-year-old popu-








45e49 3.1 (1.9e4.3) 0.7 (0.1e1.2) 2.4 (1.3e3.5)
50e54 3.7 (2.5e4.9) 0.8 (0.3e1.3) 2.9 (1.9e4.0)
55e59 4.7 (3.5e6.0) 1.7 (1.0e2.4) 3.1 (2.1e4.0)
60e64 7.1 (5.3e8.9) 2.3 (1.3e3.3) 4.8 (3.3e6.3)
65e69 5.8 (3.9e7.7) 1.3 (0.4e2.3) 4.5 (2.8e6.2)
Male 4.0 (3.0e5.0) 1.2 (0.7e1.7) 2.7 (1.9e3.6)
Female 5.2 (4.4e6.1) 1.4 (1.0e1.9) 3.8 (3.1e4.6)
Total 4.7 (4.1e5.4) 1.3 (1.0e1.7) 3.4 (2.8e4.0)
1 CI ¼ confidence interval.
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of an abnormality in the levator aponeurosis like a tear, strain,
or disinsertion. The demographic characteristics of these in-
dividuals have been studied in several case series which
described a dominant hereditary transmission mode for the
congenital type and the role of family history as well as its
management, treatment, and surgery.1,6,7 However, few
population-based studies have studied the prevalence of ptosis,
and the geographical distribution and epidemiology of this eye
problem is not well known.1,8,9 A review of previous studies
shows that the prevalence of ptosis in children is under 1% and
has been reported up to over 10% in the elderly.8,9 Due to the
lack of population-based studies on the prevalence of upper
eyelid ptosis, here we aim to describe ptosis prevalence in a
population of 45- to 69-year-olds.
Methods
The present report is part of the second phase of the
Shahroud Eye Cohort Study. The prevalence of upper eyelid
ptosis in this report is based on data from the second phase of
this study which was conducted cross-sectionally in 2014.
The methodology and sampling approach of this study have
already been published, and here we review it briefly.10 In the
first phase during 2009, using a multi-stage cluster sampling,
300 clusters of 40- to 64-year-olds in Shahroud city were
selected. In each cluster, at least twenty 40- to 64-year-old
individuals were selected for participation in the study, and
they were invited for a thorough ophthalmic examination. In
the first phase, 6311 people were selected, and 5190 (82.2%)
participated in the study. In 2014, the second phase of this
study was done. All participants of the first phase were invited
to have eye examinations in the second phase, and 4737
(91.3%) participated. After obtaining informed consent, all
respondents were first interviewed and tested for non-
cycloplegic refraction using autorefraction with the Nidek
ARK-510A. Then uncorrected visual acuity at near and far
was measured, and autorefraction results were refined by an
optometrist using the Heine Beta 200 retinoscope. Using the
information obtained up to this stage, subjective refraction was
done for those with vision worse than 20/20. In the next stage,
slit lamp examination was performed by an ophthalmologist
who also determined the presence or absence of upper eyelid
ptosis. Ptosis was considered present when the upper lid laid
more than 2 mm below the superior corneal limbus. We also
used corneal astigmatism data extracted from ocular biometric
examinations.Statistical analysisWe determined the prevalence of unilateral and bilateral
ptosis as well as ptosis in at least one eye along with 95%
confidence intervals (CI). In calculating 95% CI and standard
errors, the cluster sampling method was considered. To
investigate relationships, t-test and logistic regression were
used, and odds ratios (OR) were calculated.Ethical issuesThe Ethics Committee of Shahroud University of Medical
Sciences approved the study protocol, which was conducted in
accord with the tenets of the Helsinki Declaration. All par-
ticipants signed a written informed consent.
Results
In the second phase of the Shahroud Eye Cohort Study,
which was conducted five years after the first phase, 453 of the
original participants did not participate due to death, migra-
tion, or unwillingness, and eventually 4737 were studied;
58.9% (2791 people) of them were female. For 36 people,
ptosis data was missing, and eventually, this report was pre-
pared using data from 4701 people. The mean age of the study
participants was 55.9 ± 6.2 years (44- to 69-year-olds).
The prevalence of ptosis was 4.7% (95%CI: 4.1e5.4);
27.7% of cases were bilateral. The prevalence of bilateral
ptosis was 1.3% (95% CI: 1e1.7), and unilateral ptosis was
3.4 (95% CI: 2.8e4). Table 1 describes the prevalence of
upper eyelid ptosis in men and women by age groups. The
prevalence of ptosis was 5.2% in women and 4.0% in men
( p ¼ 0.064; OR ¼ 1.33, 95% CI: 0.98e1.80).
As demonstrated in Table 1, the prevalence of ptosis
significantly increased from 3.1% in the 45- to 49-year age
group up to 7.1% in the 60- to 64-year-old age group, and then
it reached 5.8% in the 65- to 69-year-old age group. The Chi 2
for trend test showed significant changes in the prevalence of
ptosis in different age groups ( p < 0.001). The prevalence of
ptosis in patients with a history of intraocular surgery in this
study was not significantly different from those without a
history of eye surgery ( p ¼ 0.678).
In a multiple logistic regression model, the relationship of
the variables of age, education, gender, hypertension, dysli-
pidemia, and diabetes was studied. The results of this model
are summarized in Table 2. The 60- to 64-year age group had a
higher prevalence of ptosis compared to 45- to 49-year-olds.
Also, diabetes and hypertension were directly associated with
the prevalence of ptosis.
Mean corneal astigmatism was 1.2 diopter (95% CI:
0.87e1.18) in ptotic eyes and 0.87 diopter (95% CI:
Table 2
Results of the multiple logistic regression model on the associations of ptosis
with age and gender, diabetes, and hypertension.
OR (95% confidence interval) p-Value
Age groups
45e49 1 e
50e54 1.17 (0.70e1.95) 0.542
55e59 1.44 (0.90e2.32) 0.130
60e64 2.15 (1.32e3.49) 0.002
65e69 1.65 (0.96e2.83) 0.071
Diabetes (yes/no) 1.53 (1.16e2.02) 0.003
Hypertension (yes/no) 1.41 (1.03e1.92) 0.031
OR: Odds ratio.
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was statistically significant ( p ¼ 0.013). The prevalence of
corneal astigmatism more than 1.0 diopter was 32.4% (95%
CI: 24.5e40.3) and 28.5% (95% CI: 27.2e29.9) in ptotic and
non-ptotic individuals, respectively ( p ¼ 0.327).
The prevalence of with-the-rule, against-the-rule, and
oblique astigmatism was 20.4%, 7.0%, and 4.9%, respectively,
in cases of ptosis, and 17.5%, 7.6%, and 3.4%, respectively,
for non-ptotic cases.
Discussion
This study describes the prevalence of ptosis and some of
its associated factors and provides valuable information
regarding this eye problem in Iran. The prevalence of ptosis
was 4.7%, and 1.3% of the cases had bilateral ptosis. The only
study that has addressed ptosis prevalence in Iran is the Tehran
Eye Study9 which showed that the prevalence of ptosis in 40-
to 59-year-olds was 1.16%, and this figure was 1.87% for over
60 year olds. As demonstrated in this study, ptosis prevalence
is considerably higher than the Tehran Eye Study. Sridharan
et al.8 reported an 11.5% prevalence for ptosis in a sample of
400 adults over 50 years old in Manchester. Griepentrog et al.1
also showed there is one case of congenital ptosis in every 842
births. In a 5-year study by Baiyeroju and Oluwatosin11 in
Nigeria, ptosis prevalence was reported 2.1%. In their study,
52% of patients were under 16 years old, and only 8% were
over 50 years old. Due to the lack of population-based studies
on the prevalence of ptosis, a comparison of results can be a
little difficult; however it seems that the prevalence of ptosis in
this study is not low. About 28% of ptosis cases in this study
were bilateral. Results of other studies are not much different
from ours, and most studies showed that 60e70% of ptosis
cases are unilateral.6,8 As the findings of this study indicated,
the prevalence of ptosis significantly increased with age after
the age of 60.9 This finding has been shown in previous studies
as well. Senile ptosis occurs due to an anomaly of the levator
aponeurosis such as a tear, strain, or disinsertion as a result of
aging. On the other hand, in the elderly, the levator muscle
degeneration or thinning of aponeurosis with aging may lead
to senile ptosis or involutional ptosis. However, ocular surgery
such as cataract and glaucoma filtration surgery in older ages
can cause acquired ptosis. However, in this study no statisti-
cally significant differences were observed between patientswith and without a history of intraocular surgery. For this
reason, it seems that a major part of the people in this study
have involutional ptosis. As we observed, ptosis was less
prevalent in the 65- to 69-year-old age group compared to the
60- to 64-year-olds. This is a little hard to justify; while the
lower prevalence in this age group can be a coincidence, the
age cohort effect on variations in ptosis prevalence should not
be overlooked.
According to the multiple logistic regression model, in
addition to age, diabetes and hypertension significantly
correlated with the prevalence of ptosis; since age existed in
the model, the effect of age is well controlled for. Few studies
have examined the relationship between systemic diseases and
ptosis. Bosco et al.12 have discussed the relationship between
diabetes and ptosis. In Korea, Moon and Lee demonstrated a
higher prevalence of ptosis among diabetics. Although there
was no association between dyslipidemia and the prevalence
of ptosis in our study, Shirado13 believes it is a possible
determinant of age-related involutional ptosis. The relation-
ship between diabetes and ptosis is due to a neurological
disorder. Neurogenic ptosis is usually caused by oculomotor
nerve paralysis or Horner's syndrome. Oculomotor nerve
dysfunction may exist anywhere in its path from its beginning
in the oculomotor nucleus in the midbrain to its peripheral
innervations in extraocular muscles within the orbit.
We examined corneal astigmatism in ptotic and non-ptotic
cases and found significantly higher degrees of corneal
astigmatism in the former group. A report by Ugurbas‚ and
Zilelioglu14 indicated that people with ptosis are more
involved with astigmatism, and their topographic map is
mostly bow tie. The main cause of astigmatism in these cases
could be lid pressure and impact on corneal curvature. Also, as
we demonstrated here as well, people with ptosis have with-
the-rule astigmatism. This astigmatism is created due to lid
pressure in the with-the-rule meridian. Therefore, astigmatism
should be assessed for ptotic people who have not received
refractive correction.
It should be noted that the present study has strong and
weak points. The main strength of this study is presenting the
prevalence of ptosis in the 44- to 69-year population and the
high sample size; however, the lack of classification of the
causes of the type of ptosis appearance is one of the weak
points of this study that should be noted. Due to the age dis-
tribution of the participants, we cannot consider most of them
to be congenital, and a portion of ptosis cases in this study is
acquired. Another limitation was that we did not have specific
exclusion criteria for assessing ptosis and so some patients
may have had external ocular surgery including lid and ocular
muscle surgery that could change the results and the estimated
prevalences.
In conclusion, through the present report, valuable infor-
mation regarding the prevalence of ptosis in a population of
45- to 69-year-olds is provided. The prevalence of ptosis in
this study was considerably high and significantly increased
with age. Diabetes and high blood pressure were among sys-
temic diseases directly related to the prevalence of ptosis in
this study. Astigmatism degree was significantly higher in
145H. Hashemi et al. / Journal of Current Ophthalmology 28 (2016) 142e145ptosis eyes, thus, attention to this point, especially for cataract
surgery and intraocular lens calculation for these cases, is very
important.
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